card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate

Therapeutic Expertise

Cell and Gene Therapy (CAGT)

Providing industry-leading science and innovative laboratory solutions across the CAGT spectrum

Expert services to stay ahead of advancing science

The use of alternative treatments such as Cell and Gene Therapies (CAGT) holds great potential for bridging the gaps left by traditional treatments. These innovative CAGT clinical development programs require a suite of complex laboratory assessments to satisfy regulatory submissions and support Proof of Mechanism, Pharmacodynamic, Safety and Efficacy investigations. IQVIA Laboratories with its global laboratory network and industry leading subject matter experts, is ideally positioned to shape, validate, and deliver those biomarker assessments. IQVIA Laboratories can provide flexible, integrated Cell and Gene Therapy development solutions throughout the drug development journey, beginning with the pre-clinical phase and continuing through post-approval.

IQVIA Laboratories offers an extensive array of CAGT laboratory solutions to meet the unique demands of CAGT clinical development

cell-gene-therapy-map

Industry-Leading Technology and Expertise with a Global Footprint

genomics-tech-icon

Genomics technology

We quickly design and validate potential therapeutics and can accommodate early safety testing with specialized assays, including ddPCR, Next Generation Sequencing and single-cell portfolio.

thought-leadership-icon

Thought leadership

We offer not only laboratory testing but also expertise in the design, validation, and choosing the correct assay for your specific need.

assay - Copy

Global assays

We develop customized assays in our North Carolina laboratory and transfer them seamlessly to Beijing and other laboratories around the world.

CASE STUDY

Winning the successful approval of CAR-T in China

We are connecting across the organization and applying our collective intelligence to solve the most pressing challenges facing CAGT sponsors.

 

In just one example, a CAR-T therapeutic (YESCARTA) was approved by the FDA in 2017. An additional clinical study was set up in China in 2018 and was awarded to IQVIA Laboratories.

 

  • Study title: An Open-Label Clinical Study for Evaluating the Safety and Efficacy of FKC876 in the Treatment of Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma (NHL)
  • Phase 1-2 (bridging study)
  • Enrollment: 15
  • Indications: R/R large B cell lymphoma, including DLBCL, PMBCL, HGBCL, TFL.
  • Primary endpoint: DLT, ORR
  • Secondary endpoint: AE, PFS, DOR, OS
  • Exploratory endpoint: FKC876 expansion and persistence in blood and correlation with efficacy; PD marker and predictive biomarker correlation with efficacy; FKC876 expansion/PD marker correlations with CRS and neurotoxicity; gene mutations correlations with efficacy. 

Category

Biomarkers

Matrix

Method

PK

CD19 CAR-T cell expansion

PBMC

qPCR

ADA

anti-FKC876 antibodies

Serum

ELISA

RCR monitoring

RCR performed on PBMC samples

PBMC

qPCR

Biomarkers

IL6, IL 15, IL1ra, IL2Rα, IFNγ, IL10, IL 8, MCP-1, IL2, GM-CSF, TNFα, IP-10, VCAM-1, Granzyme B

Serum

MSD

CD19, CD20, PD-L1

FFPE

IHC

 

Get in touch

Talk to us about how we can help speed your cell and gene therapies to patients who need them.

Contact us

Related Services

card-3275_Young scientist works in modern laboratory

Central Laboratory Services

Learn more
card-3285_Cropped picture of lab assistant putting flasks with urine samples into machine.

Assay Development Services

Learn more
card-3285_Cropped picture of lab assistant putting flasks with urine samples into machine.

Biomarker Development Services

Learn more
card-3285_Cropped picture of lab assistant putting flasks with urine samples into machine.

Cell and Gene Therapy Solutions

Learn more
card-3235_Pipetting robot laboratory

Clinical Laboratory Services

Learn more
card-3285_Cropped picture of lab assistant putting flasks with urine samples into machine.

Immunoassay Services

Learn more
card-3216_Biochemistry expert scientific with eyeglasses

Lab Data Management Solutions

Learn more
card-3263_Hand in blue glove holding glass histology slides

Central Laboratory PBMC Services

Learn more
card-3232_Laboratory assistant putting test tubes into the holder

Pediatric Drug Development Services

Learn more
card-3216_Biochemistry expert scientific with eyeglasses

Clinical Laboratories Project Management & Site Support

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer

Clinical Trial Flow Cytometry Services

Learn more
card-3216_Biochemistry expert scientific with eyeglasses

Translational Science and Innovations Laboratory Services (TSAIL)

Learn more
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate

Clinical Genomics Laboratory Services

Learn more

Related Insights

Specifica Antibody Discovery Campaigns

Specifica Library Platform Transfer

Specifica Affinity Maturation & Developability Optimization

Discovery Sciences – Innovative Antibody Drug Discovery Services

Immunogenicity Assessment and Functional Testing of Candidate Therapeutics

Presented by Chloe Ackaert, PhD at AAPS PharmSci360 in 2023

Multiplex Immunoassays for Idiopathic Pulmonary Fibrosis

TruCulture®: Whole blood collection and culture system for clinical studies

Unleashing the power of MHC Associated Peptide Proteomics: Immunogenicity Assessment of Oncology Drugs

In vitro functional evaluation of immuno-oncology drug candidates in customized bioassays

Monoclonal Antibodies Reagents

See All